Ian Bezek

Ian Bezek

InvestorPlace Contributor

Ian Bezek earned his economics degree from Colorado State University in 2010. He then worked as an analyst for Kerrisdale Capital, a New York City-based activist hedge fund, from 2011-13. Since then, Ian has focused on finding under-the-radar investment opportunities, particularly overseas. To that end, he taught himself Spanish and has lived in Mexico and Argentina among other countries. He currently resides in Colombia with his family.

You can interact with Ian on Twitter.

Recent Articles

Sorrento Stock Needs to Show Results

By Ian Bezek, InvestorPlace Contributor

Sorrento has a ton of interesting clinical work going on. But with Covid-19 science rapidly advancing, SRNE stock doesn't have much time left to cash in.

3 Reasons Why Nio Stock Isn’t the Next Tesla

By Ian Bezek, InvestorPlace Contributor

Nio has enjoyed an incredible turnaround this year. But Nio stock's valuation has run far ahead of where Tesla was when it was still an upstart company.

Covid-19 Therapeutics May Push Novavax Out of the Spotlight

By Ian Bezek, InvestorPlace Contributor

Novavax has used its 15 minutes of fame to great success. But unless its Covid-19 vaccine launches soon, NVAX stock is set to decline.

If You Can Tolerate Sea-Sickness, Carnival Is a Speculative Buy

By Ian Bezek, InvestorPlace Contributor

As long as the pandemic stays under control, Carnival stock has passed through the worst of the storm and will see better days going forward.

The 7 Best Energy Stocks to Close Out 2020 

By Ian Bezek, InvestorPlace Contributor

It has been a lousy year for the energy sector, but a turnaround may be near. Here are the seven best energy stocks to buy now.

SwitchBack Energy Is One to Watch, But the Price Isn’t Right

By Ian Bezek, InvestorPlace Contributor

The Switchback Energy/ChargePoint merger will create a promising company. But the value of SBE stock is too high to justify an investment yet.

7 Risky Stocks Still in Danger From Covid-19

By Ian Bezek, InvestorPlace Contributor

Following news that President Donald Trump tested positive for Covid-19, it is time to sell these seven risky stocks.

Facebook Stock Is Still the Best Play in the FAANG Group

By Ian Bezek, InvestorPlace Contributor

Covid-19 has slowed down Facebook stock more than many of its tech rivals. However, the long-term outlook of the shares remains attractive.

Best ETFs for 2020: iShares Russell 2000 Growth ETF Surges to New Highs

By Ian Bezek, InvestorPlace Contributor

As the economy recovers from Covid-19, small-cap growth companies are surging. That makes the IWO ETF among the best ETFs to buy.

Don’t Buy the Dip: Alteryx Stock Is in Real Trouble Now

By Ian Bezek, InvestorPlace Contributor

Many analysts are bullish on AYX stock after the company's terrible Q2 earnings. But risk is elevated, as Alteryx's growth story has serious doubts.

Load More